Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,301 | 8,410 | -70,499 | -53,990 | -28,922 |
| Depreciation Amortization | 573 | 1,169 | 671 | 387 | 143 |
| Accounts receivable | -1,687 | 414 | 509 | 485 | 124 |
| Other Working Capital | -5,016 | -29,629 | -28,391 | -19,757 | -12,370 |
| Other Operating Activity | 5,710 | 14,149 | 10,135 | 6,920 | 2,722 |
| Operating Cash Flow | $-23,721 | $-5,487 | $-87,575 | $-65,955 | $-38,303 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 13,799 | -19,926 | 144,062 | 104,341 | 36,959 |
| PPE Investments | 70 | -349 | -182 | N/A | N/A |
| Investing Cash Flow | $13,869 | $-20,275 | $143,880 | $104,341 | $36,959 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 688 | 39,140 | 671 | 276 | 75 |
| Financing Cash Flow | $688 | $39,140 | $671 | $276 | $75 |
| Beginning Cash Position | 32,091 | 18,713 | 18,713 | 18,713 | 18,713 |
| End Cash Position | 22,927 | 32,091 | 75,689 | 57,375 | 17,444 |
| Net Cash Flow | $-9,164 | $13,378 | $56,976 | $38,662 | $-1,269 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,721 | -5,487 | -87,575 | -65,955 | -38,303 |
| Capital Expenditure | N/A | -349 | -182 | N/A | N/A |
| Free Cash Flow | -23,721 | -5,836 | -87,757 | -65,955 | -38,303 |